Very interesting mactrader, it seems PFS measurement may be a dubious indicator of what's going on with the tumour. Its a pity Prima chose to use it as a major benchmark. I wonder exactly how many approved immunotherapy drugs had a similar poor PFS result then good OS, compared to how often both good PFS and OS was achieved.
endpoints for immunotherapy, page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.8¢ |
Change
-0.098(22.4%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 23.0¢ | $13.09M | 40.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 222909 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 223731 | 13 |
View Market Depth
| Last trade - 14.38pm 27/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |